These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12559509)

  • 1. Hypoxia-like tissue injury as a component of multiple sclerosis lesions.
    Lassmann H
    J Neurol Sci; 2003 Feb; 206(2):187-91. PubMed ID: 12559509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.
    Aboul-Enein F; Rauschka H; Kornek B; Stadelmann C; Stefferl A; Brück W; Lucchinetti C; Schmidbauer M; Jellinger K; Lassmann H
    J Neuropathol Exp Neurol; 2003 Jan; 62(1):25-33. PubMed ID: 12528815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors and binding proteins in multiple sclerosis plaques.
    Gveric D; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):215-25. PubMed ID: 10417663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
    Marik C; Felts PA; Bauer J; Lassmann H; Smith KJ
    Brain; 2007 Nov; 130(Pt 11):2800-15. PubMed ID: 17956913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of demyelinating disease.
    Scolding NJ; Zajicek JP; Wood N; Compston DA
    Prog Neurobiol; 1994 Jun; 43(2):143-73. PubMed ID: 7972853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some aspects of histopathology in multiple sclerosis].
    Kuhlmann T; Brück W
    Rev Neurol; 2000 Jun 16-30; 30(12):1208-12. PubMed ID: 10935252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin of remyelinating cells in the central nervous system.
    Blakemore WF; Keirstead HS
    J Neuroimmunol; 1999 Jul; 98(1):69-76. PubMed ID: 10426364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: lessons from molecular neuropathology.
    Lassmann H
    Exp Neurol; 2014 Dec; 262 Pt A():2-7. PubMed ID: 24342027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of oligodendroglia pathology in multiple sclerosis.
    Ozawa K; Suchanek G; Breitschopf H; Brück W; Budka H; Jellinger K; Lassmann H
    Brain; 1994 Dec; 117 ( Pt 6)():1311-22. PubMed ID: 7820568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of demyelination and tissue damage in multiple sclerosis.
    Lassmann H
    Acta Neurol Belg; 1999 Mar; 99(1):6-10. PubMed ID: 10218087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of multiple sclerosis: new lessons from pathology.
    Brück W; Stadelmann C
    Curr Opin Neurol; 2005 Jun; 18(3):221-4. PubMed ID: 15891403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological topics of multiple sclerosis].
    Lassmann H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):715-8. PubMed ID: 20030193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of multiple sclerosis-new concepts.
    Kornek B; Lassmann H
    Brain Res Bull; 2003 Aug; 61(3):321-6. PubMed ID: 12909302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology of multiple sclerosis].
    Shirabe T
    Nihon Rinsho; 2003 Aug; 61(8):1280-3. PubMed ID: 12962012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.